Xinyuan Real Estate Co., Ltd. to Report Third Quarter 2020 Unaudited Financial Results on November 27, 2020

PR Newswire

BEIJING, Nov. 23, 2020 /PRNewswire/ — Xinyuan Real Estate Co., Ltd. (“Xinyuan” or “the Company”) (NYSE: XIN), an NYSE-listed real estate developer and property manager, today announced that it will release its unaudited financial results for the third quarter on Friday, November 27, 2020, before the U.S. market opens.

Xinyuan’s management team will host an earnings conference call to discuss its third quarter 2020 financial results on Friday, November 27, 2020 at 8:00am ET, listeners may access the call by dialing:

 

US Toll Free:    

1-800-458-4121

Toll/International:  

1-323-794-2093

China National:  

4001 209101

Hong Kong Toll Free:

800 961 105

United Kingdom Toll Free:

0800 358 6377

 

A replay of the conference call may be accessed by phone at the following numbers until December 4, 2020:

 

US:

1-844-512-2921

International:

1-412-317-6671

Access code:

4456736

 

A live and archived webcast of the conference call will be available at http://ir.xyre.com

A live broadcast will be also available at Roadshowing and FUTU platform, the links are as follows:

https://www.roadshowing.com/roadshowing/info.html?id=31611

https://q.futunn.com/nnq/detail?id=105258217242628

About Xinyuan Real Estate Co., Ltd.

Xinyuan Real Estate Co., Ltd. (“Xinyuan”) is an NYSE-listed real estate developer and property manager primarily in China and recently in other countries. In China, Xinyuan develops and manages large scale, high quality real estate projects in over ten tier one and tier two cities, including Beijing, Shanghai, Tianjin, Zhengzhou, Jinan, Qingdao, Chengdu, Xi’an, Suzhou, Dalian, Zhuhai and Foshan. Xinyuan was one of the first Chinese real estate developers to enter the U.S. market and over the past few years has been active in real estate development in New York. Xinyuan aims to provide comfortable and convenient real estate related products and services to middle-class consumers. For more information, please visit http://www.xyre.com.

Investor Contact:

For more information, please contact:

In China:

Xinyuan Real Estate Co., Ltd.
Mr. Charles Wang
Investor Relations Director
Tel: +86 (10) 8588-9376
Email: [email protected]

The Blueshirt Group                                                                 
Ms. Susie Wang
Mobile: +86 (138) 1081-7475
Email: [email protected]

In the United States:

The Blueshirt Group
Ms. Julia Qian
Email: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/xinyuan-real-estate-co-ltd-to-report-third-quarter-2020-unaudited-financial-results-on-november-27-2020-301178743.html

SOURCE Xinyuan Real Estate Co., Ltd.

Houlihan Lokey Adds Experienced Tax Advisor to Its Financial and Valuation Advisory Business

Houlihan Lokey Adds Experienced Tax Advisor to Its Financial and Valuation Advisory Business

Tom Goldrick Joins as a Managing Director and Head of M&A Tax Services

CHICAGO–(BUSINESS WIRE)–
Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, today announced that Tom Goldrick has joined the firm’s Transaction Advisory Services practice as a Managing Director and Head of M&A Tax Services. He is based in Chicago.

Mr. Goldrick joins following a 13-year career at KPMG, where he was most recently a Managing Director in its Mergers & Acquisitions Tax practice focused on providing buyside and sellside tax consulting services to both financial sponsors and strategic buyers. During his time there, he was instrumental in developing cross-border tax models under both pre- and post-tax reform frameworks and has advised on transactions in North America, Europe, and the Asia-Pacific region. Mr. Goldrick’s tax due diligence experience spans numerous sectors, including industrials, healthcare, technology, financial services, and retail.

“We are delighted that Tom has joined our team to help our clients in the U.S. and around the world navigate these changing times,” said Sean Murphy, Head of Transaction Advisory Services at Houlihan Lokey. “His experience in comparative modeling around tax reform and its potential impact on M&A transactions will be tremendously valuable to our clients in the U.S. going forward, and his equally impressive international experience will assist both U.S. multinationals and our international clients. We’re excited to introduce him to our clients as they increasingly seek the kind of expertise Tom possesses,” he added.

“Houlihan Lokey’s leadership across its businesses, global footprint, and depth of M&A due diligence expertise made this a perfect fit for me,” said Mr. Goldrick. “I am eager to continue the growth of the firm’s M&A Tax Services and work across Financial and Valuation Advisory, Corporate Finance, and Financial Restructuring to develop the most compelling and comprehensive tax structuring and diligence offerings in financial services for our clients around the world.”

Mr. Goldrick holds a B.B.A. in Accountancy from the University of Notre Dame and is a licensed CPA in the state of Illinois.

About Houlihan Lokey

Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. Houlihan Lokey is the No. 1 M&A advisor for the past five consecutive years in the U.S., the No. 1 global restructuring advisor for the past six consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 20 years, all based on number of transactions and according to data provided by Refinitiv (formerly Thomson Reuters).

Investor Relations

212.331.8225

[email protected]

Media Relations

John Gallagher

212.497.4220

[email protected]

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Banking Accounting Professional Services Finance

MEDIA:

Cannabix Technologies to Beta Test Marijuana Breathalyzer with Occupational Health Clinic in Southern California to Meet Workplace Drug Testing Needs

Cannabix is developing the Cannabix Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety

VANCOUVER, British Columbia, Nov. 23, 2020 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that it plans to begin beta testing its version 3.0 THC Breath Analyzer (“THCBA”) in southern California with an occupational health care provider located in Newport Beach. Cannabix expects to deliver its latest version of the THCBA to Alipour Medical Centre early in the new year. Alipour Medical Centre provides drug and alcohol testing services to a number of local employers in the state. The THCBA is an ideal device for employers and other markets who are seeking a way to quickly, easily and non-invasively test for recent use of ∆9-tetrahydrocannabinol (“THC”) – the psychoactive component of marijuana that causes impairment. Cannabix will be seeking additional organizations for beta testing and welcomes interested parties to contact us via our website (cannabixtechnologies.com).

Employers everywhere are struggling with the limitations of current drug testing technology in identifying recent use of marijuana that may be causing impairment during work hours and differentiating this from recreational and medical use during nonwork hours/days.

The Cannabix device allows for more relevant THC detection from breath allowing employers to create an onsite regiment whereby they can perform pre-access testing for recent use of marijuana before and during work hours, instead of testing for drug use when employees are not at work. Cannabix will be beta testing its device in order to continue training the device’s machine learning database and improve user experience through testing feedback. The THCBA has been built to provide easy to understand screen prompts for the positive and negative detection of THC in breath in a portable manner, and can be administered without extensive training.

Current forms of testing for marijuana use can identify THC ranging from minutes to days prior to actual use, making it impossible to show the difference between the two.  Studies¹ have shown that breath is a better indicator of impairment than saliva, blood, or urine because THC is present in breath for a relatively short period of time (1-3 hours); whereas, it is excreted at detectable levels in other body fluids for many hours, days, or even weeks after smoking. This short time period of detection in breath aligns with the peak impairment window. 

Dr. Nima Alipour, CEO of Alipour Medical Corp, stated, “We are very pleased to be using one of the world’s first marijuana breathalyzers in our medical facility. We know first-hand how the legalization of marijuana has affected employers in our state.  As occupational health practitioners based in Orange County, we understand the challenges that employers are facing in providing relevant drug testing for existing and new employees.  We advise corporations on how best to keep their workforce safe; identifying safety issues as they pertain to impairment, while taking into account employee rights in an environment of state legalization. Alipour Medical prides itself on deploying cutting edge technology in our practice and we look forward to helping with research, and ultimately beta testing devices alongside Cannabix Technologies in California.”

Parties interested in working with Cannabix to beta-test its Cannabix Marijuana Breathalyzer are encouraged to contact the Company at [email protected]

(1) Olla P, Ishraque MT, Bartol S. 2020. Evaluation of Breath and Plasma Tetrahydrocannabinol Concentration Trends Postcannabis Exposure in Medical Cannabis Patients. Cannabis and Cannabinoid Res.; 99-104.
 
Himes S. et al. 2013. Cannabinoids in Exhaled Breath following Controlled Administration of Smoked Cannabis. Clinical Chemistry; 1780–1789.
 
Beck O, Sandqvist S, Dubbelboer I, Franck J. 2011. Detection of delta9-tetrahydrocannabinol in exhaled breath collected from cannabis users. J Anal Toxicol; 35:541– 4.

About Cannabix Technologies Inc.

Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace. Cannabix has established breath testing technologies in the pursuit of bringing accurate, durable, portable tools to market to enable detection of marijuana-impaired driving offences on roads at a time when marijuana is becoming legal in many global jurisdictions. Cannabix is working to develop drug-testing devices that will detect THC- the psychoactive component of marijuana that causes intoxication- using breath samples. In particular, Cannabix is focused on developing breath testing devices for detection of recent use of THC, in contrast to urine testing for THC metabolite that requires an invasive collection and reflects usage, days or even weeks earlier. The devices will also be useful for other practical applications such as testing employees in the workplace where impairment by THC can be hazardous.

We seek Safe Harbor.

On behalf of the Board of Directors

“Rav Mlait”

CEO
Cannabix Technologies Inc.

For further information, contact the Company at [email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company, such as final development of a commercial or prototype product(s), successful trial or pilot of company technologies, no assurance that commercial sales of any kind actually materialize; no assurance the Company will have sufficient funds to complete product development. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks regarding protection of proprietary technology; (iii) the ability of the Company to complete financings; (iv) the ability of the Company to develop and market its future product; and (v) risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the marijuana breathalyzer business will provide any benefit to the Company, and no assurance that any proposed new products will be built or proceed. There is no assurance that existing “patent pending” technologies licensed by the Company will receive patent status by regulatory authorities. The Company is not currently selling commercial breathalyzers. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.



Noble Holding Corporation plc Announces Confirmation Of Plan Of Reorganization

PR Newswire

SUGAR LAND, Texas, Nov. 23, 2020 /PRNewswire/ — Noble Holding Corporation plc (OTC-PINK: NEBLQ, the Company) announced today that the United States Bankruptcy Court for the Southern District of Texas has issued an order approving the Company’s Joint Plan of Reorganization (the “Plan”).  The Company is working towards emergence as soon as possible upon receipt of certain regulatory approvals which could be received late this year or early 2021.

The Plan received widespread support from creditors and upon emergence will equitize all outstanding bond debt, which currently totals $3.4 billion, and provide for a new $200 million investment in the form of second lien notes as well as a new $675 million secured credit facility.

Robert W. Eifler, President and Chief Executive Officer of the Company, stated, “We are pleased to have reached this critical milestone and are eager to continue executing on our strategy.  I would like to thank our creditors, customers, vendors, advisors and employees, whose support throughout this process has been critical to reaching a consensual and efficient restructuring while maintaining our industry-leading operations.  We look forward to emerging with a significantly improved balance sheet and remain committed to delivering the operational excellence that our customers have come to expect from Noble.”

About Noble Holding Corporation plc
In November 2020, Noble Corporation plc changed its name to Noble Holding Corporation plc to allow the ultimate parent company that emerges from the Chapter 11 reorganization to use the name “Noble Corporation plc.” Noble is a leading offshore drilling contractor for the oil and gas industry. The Company owns and operates one of the most modern, versatile and technically advanced fleets in the offshore drilling industry. Noble performs, through its subsidiaries, contract drilling services with a fleet of 19 offshore drilling units, consisting of 7 drillships and semisubmersibles and 12 jackups, focused largely on ultra-deepwater and high-specification jackup drilling opportunities in both established and emerging regions worldwide. Noble is a public limited company registered in England and Wales with company number 08354954 and registered office at 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, WA14 2DT. Additional information on Noble is available at www.noblecorp.com.

Forward-looking Disclosure Statement
Statements regarding Chapter 11 proceedings, including timing of emergence, stock exchange listing and related timing, as well as any other statements that are not historical facts in this release, are forward-looking statements that involve certain risks, uncertainties and assumptions. These include but are not limited to regulatory and legal approvals, consents and reviews, actions or claims by regulatory authorities, customers and other third parties, operating hazards and delays, risks associated with operations outside of the U.S., legislation and regulations affecting drilling operations, compliance with regulatory requirements, factors affecting the level of activity in the oil and gas industry, supply and demand of drilling rigs, factors affecting the duration of contracts, the actual amount of downtime, violations of anti-corruption laws, hurricanes and other weather conditions, public health threats including the COVID-19 (Coronavirus Disease 2019) pandemic, market conditions, the future price of oil and gas and other factors detailed in the Company’s most recent Form 10-K, Form 10-Q’s and other filings with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated.

Cision View original content:http://www.prnewswire.com/news-releases/noble-holding-corporation-plc-announces-confirmation-of-plan-of-reorganization-301178882.html

SOURCE Noble Corporation

Avantor® to Participate at the Evercore ISI 3rd Annual HealthCONx Virtual Conference

PR Newswire

RADNOR, Pa., Nov. 23, 2020 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the Evercore ISI 3rd Annual HealthCONx Virtual Conference on Wednesday, December 2, 2020. Michael Stubblefield, President and CEO at Avantor, will represent Avantor in the segment beginning at approximately 2:40 p.m. Eastern Time

A live webcast may be accessed through the investor relations section of Avantor’s website at https://ir.avantorsciences.com/investors/events-and-presentations/ and will be available for replay through December 31, 2020.

About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, please visit www.avantorsciences.com.

Media Contact

Allison Hosak

Senior Vice President, Global Communications
Avantor
908-329-7281
[email protected]

Investor Relations Contact

Tommy J. Thomas, CPA
Vice President, Investor Relations
Avantor
781-375-8051
[email protected]

 

Cision View original content:http://www.prnewswire.com/news-releases/avantor-to-participate-at-the-evercore-isi-3rd-annual-healthconx-virtual-conference-301178432.html

SOURCE Avantor and Financial News

WRAP Expands Ballistic Shield Product Line

Company Launches New WRAP.com Website URL

TEMPE, Ariz., Nov. 23, 2020 (GLOBE NEWSWIRE) — WRAP Technologies, Inc. (the “Company” or “WRAP”) (Nasdaq: WRTC), an innovator of modern policing solutions, announced the expansion of its WRAP Armor™ ballistic shield product line to include the Level IIIA Patrol Shield and the Molle Shield Cover in addition to the Level III Tactical Shield. 

WRAP Armor™ products are now available to view via the Company’s newly launched wrap.com website URL.

“Our vision is to become a leader in providing public safety with advanced technology solutions to help protect law enforcement officers and the citizens they serve,” said Tom Smith, President and Interim CEO at WRAP. “The introduction of our revolutionary BolaWrap® Remote Restraint device to law enforcement has enabled us to build a strong distribution network and customer base which we intend to leverage by continuing to innovate and provide public safety with needed solutions.

“We believe every officer should have access to ballistic shields in their patrol cars without needing to wait for tactical units to arrive, especially during these uncertain times of COVID and frequent rioting.”

WRAP Armor ballistic shields contain a combination of military grade polyurea exterior coating and advanced composite materials which produce superior performing shields with multi-hit capacity. The Levell III Tactical Shields start at just 16 lbs and protect against multiple rifle rounds, and the Level IIIA Patrol Shields start at 6 pounds and protect against multiple pistol rounds.

All WRAP Armor ballistic shields are NIJ 0108.01 compliant.

Ballistic shields are a component of the Ballistic Protection Materials & Equipment Market valued at $1.7 billion in 2018 and is expected to be valued at $2.4 billion by 2025 according to Global Market Insights.

About WRAP (WRTC)
WRAP Technologies, Inc. is an innovator of modern policing solutions. The Company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar® tether to restrain an individual at a distance from 10 to 25 feet. Developed by award winning inventor Elwood Norris, the Company’s Chief Technology Officer, the small but powerful BolaWrap 100 assists law enforcement in safely and effectively deescalating encounters, especially those involving an individual in crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury in a number of cities including Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth, and Oak Ridge. For information on the Company, please visit www.wrap.com.

Follow WRAP here:

WRAP on Facebook: https://www.facebook.com/wraptechnologies/
WRAP on Twitter: https://twitter.com/wraptechinc
WRAP on LinkedIn: https://www.linkedin.com/company/wraptechnologiesinc/

Trademark Information
BolaWrap and Wrap are trademarks of Wrap Technologies, Inc. All other trade names used herein are either trademarks or registered trademarks of the respective holders.

Cautionary Note on Forward-Looking Statements – Safe Harbor Statement  
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to: statements regarding the Company’s overall business; total addressable market; and, expectations regarding future sales and expenses. Words such as “expect”, “anticipate”, “should”, “believe”, “target”, “project”, “goals”, “estimate”, “potential”, “predict”, “may”, “will”, “could”, “intend”, and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Moreover, forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ability to successful implement training programs for the use of its products; the Company’s ability to manufacture and produce product for its customers; the Company’s ability to develop sales for its new product solution; the acceptance of existing and future products; the availability of funding to continue to finance operations; the complexity, expense and time associated with sales to law enforcement and government entities; the lengthy evaluation and sales cycle for the Company’s product solution; product defects; litigation risks from alleged product-related injuries; risks of government regulations; the business impact of health crises or outbreaks of disease, such as epidemics or pandemics; the ability to obtain export licenses for counties outside of the US; the ability to obtain patents and defend IP against competitors; the impact of competitive products and solutions; and the Company’s ability to maintain and enhance its brand, as well as other risk factors mentioned in the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, and other SEC filings. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

WRAP
Contact:

Paul M. Manley
VP – Investor Relations
(612) 834-1804
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/67a87c92-d7a3-40e4-8e60-c66a89260d6e



Rising Medical Costs in COVID-19 Era Threaten Holiday Spending

Aflac survey reveals consumers will reduce gift giving in half to adjust to the pandemic-led crisis

PR Newswire

COLUMBUS, Ga., Nov. 23, 2020 /PRNewswire/ — Despite pandemic economic hardships, National Retail Federation forecasting shows consumers will spend just under $1,000 this holiday season — with speculations centering on how Americans have extra cash on hand due to spending more time at home because of the pandemic. However, according to the 2020 Aflac Health Care Issues Survey released by Aflac, a leading provider of supplemental insurance and products in the U.S., the expenses health insurance doesn’t cover may make many American families cash in on this so-called “quarantine savings” to pay for out-of-pocket medical costs rather than on holiday gifts for their loved ones.

The second annual national online survey of 1,138 U.S. adults looked at how medical costs over the last two years have affected Americans during the holiday season and year-round, as well as the rate of hospital visits, regrets related to health care coverage decisions and COVID-19’s ramifications.

The ongoing rise in health care costs is hitting American families hard, and the challenges posed by the global health crisis are an aggravating factor. Among families with children under 18 in their household who visited the hospital in the past two years, 70% faced significant out-of-pocket medical expenses beyond a copay or deductible during their most recent hospital visit. Of these, 64% said they spent $500 or more in out-of-pocket costs, up from 58% in 2019, and 45% of families said they spent $1,000 or more in out-of-pocket costs, up from 37% last year.

“As a mother of three and a businesswoman, I have seen firsthand how the pandemic has shaped everything from how and where kids learn to how and where employees work,” said Stephanie Shields, senior vice president of Broker Sales at Aflac. “In a year ripe with change, one constant remains: High medical costs continue disrupting American families, many of whom may be unprepared for the out-of-pocket expenses health insurance doesn’t cover.”

Because of these financial difficulties, many families may find it difficult to fill in their loved ones’ stockings this holiday season. Within the past two years, nearly 3 in 4 (71%) families said they had to make some sort of sacrifice or hard decision during the holiday season because of medical cost concerns, including:

  • Fewer presents underneath the tree — More than 1 in 5 said they spent less on holiday gifts or went without giving them altogether (23%), decided against purchasing a gift for a loved one (21%) and reduced their overall holiday spending (21%).
  • Risky debt on the rooftop — Nearly one-third (28%) said they relied on a credit card, and 21% borrowed money from a friend or family member.
  • Home alone for the holidays — Over 1 in 5 said they canceled events (23%) and put a stop to travel plans to see family or friends (21%).

In addition, over one-third of families (37%) said they made health care coverage decisions they regret within the past two years. The top reasons for this benefits remorse include choosing a plan with limited benefits (41%), choosing too high of a deductible (40%), going to an out-of-network doctor (39%) and not sufficiently researching benefits (31%).

“It’s natural for people to have regrets after making decisions about their medical plan, which can impact their future,” said Shields. “While no one could have foreseen what’s occurred in 2020, it is essential to learn from the past and educate yourself on the role health care benefits like supplemental insurance can play in helping with the expenses health insurance doesn’t cover. Doing so can lead to greater confidence in the coverage you choose and, hopefully, fewer regrets and financial woes, meaning families can focus on getting and staying well.”

COVID-19’s Impact

At the time of the survey, 16% of families said they or a member of their household was diagnosed with or received treatment for COVID-19, making it the third top health condition among eight prevalent conditions presented that families said they faced. But its impression has been staggering: Compared to the 62% of families surveyed who said they have been to a hospital in the past two years for an outpatient procedure, an overnight stay or both, a full 3 in 4 families who faced COVID-19 said they or someone in their household required hospitalization as a result.

The top-two conditions surveyed families said they have encountered are diabetes (35%) and cancer (16%), with heart attack (14%) and stroke (13%) ranking a close fourth and fifth. According to the Centers for Disease Control and Prevention, each of these conditions is a common comorbidity putting the afflicted at a heightened risk of severe illness from COVID-19.

Interestingly, over 3 in 4 (79%) of those who said they or a household member was diagnosed with or received treatment for COVID-19 also said they faced medical expenses beyond a copay or deductible during their most recent hospital visit. Despite the reason or season, these families have had to make hard choices about their health and finances due to medical costs year-round, including relying on a credit card (44%), postponing seeing a medical professional (37%) or taking a family member to see a medical professional (33%), working extra to offset medical expenses (31%) and taking out a loan (30%).

Perhaps not surprising, for those who said they or a household member was diagnosed with or received treatment for COVID-19, 62% admit coverage regrets within the past two years.

Survey findings for all respondents, not just families with children, are also available and held steady across all groups. Learn more about the financial effects of health care issues and how Aflac can help with the expenses health insurance doesn’t cover at Aflac.com/HCI.

Methodology
The 2020 Aflac Health Care Issues Survey is a national online survey of 1,138 U.S. adults fielded in August 2020 by Hill+Knowlton Strategies. To learn more about the survey findings, visit Aflac.com/HCI.

About Aflac Incorporated

Aflac Incorporated (NYSE: AFL) is a Fortune 500 company, helping provide protection to more than 50 million people through its subsidiaries in Japan and the U.S., where it is a leading supplemental insurer by paying cash fast when policyholders get sick or injured. For more than six decades, insurance policies of Aflac Incorporated’s subsidiaries have given policyholders the opportunity to focus on recovery, not financial stress. Aflac Life Insurance Japan is the leading provider of medical and cancer insurance in Japan, where it insures 1 in 4 households. Fortune magazine recognized Aflac as one of the 100 Best Companies to Work for in America for 20 consecutive years. For 14 consecutive years, Aflac has been recognized by Ethisphere as one of the World’s Most Ethical Companies. In 2020, Fortune included Aflac Incorporated on its list of World’s Most Admired Companies for the 19th time, and Bloomberg added Aflac Incorporated to its Gender-Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation and transparency. To learn how to get help with expenses health insurance doesn’t cover, get to know us at Aflac.com.

Aflac | Aflac New York | WWHQ | 1932 Wynnton Road | Columbus, GA 31999.

Media contact: Jon Sullivan, 706.573.7610 or [email protected]

Analyst and investor contact: David A. Young, 706.596.3264 or [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/rising-medical-costs-in-covid-19-era-threaten-holiday-spending-301178560.html

SOURCE Aflac Incorporated

EHang to Report Third Quarter 2020 Unaudited Financial Results on Thursday, December 3, 2020

GUANGZHOU, China, Nov. 23, 2020 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company” ) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company, today announced that it will release its unaudited financial results for the third quarter ended September 30, 2020 on Thursday, December 3, 2020, before the U.S. market opens.

EHang’s management team will host an earnings conference call at 8:00 AM on Thursday, December 3, 2020, U.S. Eastern Time (9:00 PM on December 3, 2020, Beijing/Hong Kong Time).              

Please register in advance for the conference using the link provided below and dial in 10 minutes before the conference is scheduled to begin. Conference access information will be provided upon registration.

Participant Online Registration:
http://apac.directeventreg.com/registration/event/8538989

A replay of the conference call may be accessed by phone at the following numbers until December 11, 2020. To access the replay, please reference the conference ID 8538989.

  Phone Number
International +61 2 8199-0299
United States +1 (646) 254-3697
Hong Kong +852 800963117
Mainland China +86 4006322162
+86 8008700205

A live and archived webcast of the conference call will be available on the company’s investors relations website at http://ir.ehang.com/.

About EHang

EHang (Nasdaq: EH) is the world’s leading autonomous aerial vehicle (AAV) technology platform company. Our mission is to make safe, autonomous, and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility (UAM) industry, EHang continues to explore the boundaries of the sky to make flying technologies benefit our life in smart cities. For more information, please visit www.ehang.com.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. Management has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While they believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond management’s control. These statements involve risks and uncertainties that may cause EHang’s actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements.

Investor Contact:

[email protected]

In the U.S.: [email protected]

In China: [email protected]

Media Contact:

[email protected]



Did You Acquire (BBBY) Before October 2, 2019? Johnson Fistel Investigates Bed Bath & Beyond; Should Management be Held Accountable for Investors Losses?

PR Newswire

SAN DIEGO, Nov. 23, 2020 /PRNewswire/ — Johnson Fistel, LLP is investigating potential claims on behalf of Bed Bath & Beyond Inc. (NASDAQ: BBBY) against certain of its officers and directors. 

Recently a class action lawsuit was filed in federal court against the Company on behalf of purchasers of the securities of Bed Bath & Beyond from October 2, 2019 through February 11, 2020 (the “Class Period”).

According to the lawsuit, defendants throughout the Class Period made false and misleading statements and failed to disclose: (1) due to “aggressive disposition of inventory,” the Company lacked sufficient inventory in key categories to support holiday sales; (2) the Company’s internal control over inventory levels and financial reporting were not effective; (3) as a result of the foregoing, the Company was likely to experience reduced sales; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.


If you are a current, long-term shareholder of


Bed Bath & Beyond


, holding shares before



October 2, 2019

, you may have standing to hold Bed Bath & Beyond harmless from the alleged harm caused by the officers and directors of the Company by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing. 

If you are interested in learning more about the investigation, please contact lead analyst Jim Baker ([email protected]) at 619-814-4471. If emailing, please include a phone number. 

Additionally, you can [Click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising.  Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[email protected]

[Click here to join this action]

Cision View original content:http://www.prnewswire.com/news-releases/did-you-acquire-bbby-before-october-2-2019–johnson-fistel-investigates-bed-bath–beyond-should-management-be-held-accountable-for-investors-losses-301178871.html

SOURCE Johnson Fistel, LLP

IIROC Trading Halt – VDKA.P

Canada NewsWire

VANCOUVER, BC, Nov. 23, 2020 /CNW/ – The following issues have been halted by IIROC:

Company: Spartan Acquisition Corp.

TSX-Venture Symbol: VDKA.P

All Issues: Yes

Reason: At the Request of the Company Pending News

Halt Time (ET): 8:23 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions